PNC-27 5 mg | Anti-Cancer Research Peptide | USA Research Peptides

Brief Product Summary

PNC-27 5 mg, crafted by Generic Peptides, is a synthetic anti-cancer peptide developed for advanced research in oncology and regenerative medicine. This high-purity compound targets cancer cell membranes to induce selective cytotoxicity, offering a unique tool for studying tumor suppression and cellular repair. Manufactured in the USA, it ensures reliability and quality for cutting-edge scientific exploration.

Designed to mimic a segment of the p53 tumor suppressor protein, PNC-27 interacts with cancer-specific markers, distinguishing it from traditional peptides focused on growth or metabolism. Peptide therapy specialists value its potential to bridge anti-cancer mechanisms with regenerative outcomes, making it a multi-functional candidate for innovative research. This product is strictly for research purposes and not for human consumption.

Mechanism of Action

PNC-27 targets HDM-2 (human double minute 2) proteins overexpressed on cancer cell membranes, forming transmembrane pores that disrupt membrane integrity and induce rapid necrosis. Unlike typical apoptosis pathways, this direct cytotoxic action selectively kills cancer cells while sparing healthy cells, leveraging the differential expression of HDM-2. Its p53-derived sequence enhances its specificity for malignant cells.

The peptide's regenerative potential emerges post-tumor destruction, as it may support tissue repair by reducing inflammation and promoting healthy cell turnover in experimental models. Peptide therapy researchers use PNC-27 to study its dual role in cancer cell elimination and subsequent healing, offering insights into novel therapeutic mechanisms. Its stability and targeted action make it a standout in oncology research.

• Binds HDM-2 to form pores in cancer cell membranes
• Induces selective necrosis of tumor cells
• Spare healthy cells due to specificity
• Supports post-tumor tissue repair

Potential Research Applications

PNC-27 5 mg is a vital resource for peptide therapy specialists studying anti-cancer mechanisms and regenerative medicine. Research focuses on its ability to selectively destroy cancer cells in preclinical models, offering insights into tumor suppression and cell-specific cytotoxicity. Its unique mechanism makes it ideal for exploring novel cancer therapies.

Additional applications include studies of tissue regeneration following tumor elimination, where PNC-27's potential to reduce inflammation and promote healing is examined. It's also used to investigate cancer cell resistance and combination therapies, leveraging its multi-functional properties. This peptide's versatility drives research into oncology and regenerative outcomes.

• Tumor suppression and cytotoxicity studies
• Post-tumor tissue regeneration research
• Cancer cell resistance and therapy combination experiments
• Inflammation reduction modeling

Key Features & Benefits

PNC-27 5 mg from Generic Peptides delivers exceptional purity and specificity, essential for anti-cancer and regenerative research. Its high solubility and stability ensure versatility across experimental designs, from in vitro cytotoxicity assays to in vivo tumor models. Produced in the USA, it meets rigorous quality standards and offers rapid domestic shipping.

The peptide's selective cytotoxicity and regenerative potential provide a robust platform for studying cancer cell elimination and tissue repair. Its precision and multi-functional action make it a top choice for labs advancing therapeutic research. PNC-27 5 mg is engineered to push the boundaries of oncology and healing science.

• Purity >98% for consistent results
• USA-sourced for quality and speed
• Stable and soluble for diverse applications
• Optimized for anti-cancer and regenerative research

Product Specifications

PNC-27 5 mg is supplied as a lyophilized powder in a sterile vial, designed for stability in research environments. Each batch undergoes HPLC and mass spectrometry testing, confirming purity exceeding 98%. Its molecular formula, C₁₈₈H₂₉₃N₅₃O₄₄S, and molecular weight of 4030.7 g/mol ensure accurate dosing for oncology studies.

Reconstitute with 1-2 mL of bacteriostatic water or saline for optimal solubility. Store at 2-8°C, protected from light and heat, to maintain its integrity. This product is intended solely for laboratory research by qualified professionals, not for human or therapeutic use.

• Form: Lyophilized powder
• Purity: >98% (HPLC verified)
• Solubility: Bacteriostatic water or saline
• Storage: 2-8°C, protected from light

Legal Disclaimer

For research use only. Not for human consumption. This product is intended solely for laboratory research by qualified professionals and is not approved for medical, therapeutic, or diagnostic use.

Frequently Asked Questions (FAQ)